CIP2A expression is increased in prostate cancer
Open Access
- 21 October 2010
- journal article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 29 (1), 136-4
- https://doi.org/10.1186/1756-9966-29-136
Abstract
The CIP2A protein is a recently characterized oncoprotein which inhibits protein phosphatase 2A activity. Expression of CIP2A has been detected in several carcinomas, but its expression and significance in prostate cancer has not been examined so far.Keywords
This publication has 11 references indexed in Scilit:
- Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathwaysJournal of Medical Microbiology, 2010
- CIP2A Is Associated with Human Breast Cancer AggressivityClinical Cancer Research, 2009
- MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric CancerJNCI Journal of the National Cancer Institute, 2009
- CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor CellsClinical Cancer Research, 2008
- Protein phosphatase 2A regulatory subunits and cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2008
- CIP2A Inhibits PP2A in Human MalignanciesCell, 2007
- Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor‐associated antigensThe Prostate, 2005
- Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen EraJournal of Clinical Oncology, 2003
- Cloning and characterization of a novel 90 kDa ‘companion’ auto-antigen of p62 overexpressed in cancerOncogene, 2002
- The development of androgen-independent prostate cancerNature Reviews Cancer, 2001